| Dr Mindy Ann Werner-crohn, MD | |
|
2930 Domingo Ave # 218, Berkeley, CA 94705-2454 | |
| (818) 756-0050 | |
| (844) 756-0054 |
| Full Name | Dr Mindy Ann Werner-crohn |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 2930 Domingo Ave # 218, Berkeley, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033240155 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | G53827 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mindy Ann Werner-crohn, MD 2930 Domingo Ave # 218, Berkeley, CA 94705-2454 Ph: (818) 756-0050 | Dr Mindy Ann Werner-crohn, MD 2930 Domingo Ave # 218, Berkeley, CA 94705-2454 Ph: (818) 756-0050 |
News Archive
Intellect Neurosciences, Inc. a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has obtained an initial draft report of the Company's Phase 1b clinical trial for its lead Alzheimer's candidate, OXIGON (OX1).
Adults younger than 45 years who reported recently using cannabis were 2 times more likely to have had a heart attack (myocardial infarction), and this link was stronger in frequent users, according to new research in CMAJ.
Madeleine Bordallo, the U.S. delegate from Guam, has introduced legislation that would fund a survey to collect health data from Native Hawaiians and Pacific Islanders, the Pacific Daily News reports.
A new study has confirmed what researchers already suspected to be the case: heat inactivates SARS-CoV-2 in human milk.
VioQuest Pharmaceuticals today announced that the United States Patent and Trademark Office has issued the first patent for the company's investigational product candidate Lenocta (sodium stibogluconate). U.S. Patent No. 7,416,723 entitled "Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases," encompasses novel compositions including Lenocta for the treatment of cancer and a broad range of other diseases.
› Verified 1 days ago
Rebecca Carrillo, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2640 Martin Luther King Jr Way, Berkeley, CA 94704 Phone: 510-981-5290 Fax: 510-981-5265 | |
Dr. Peter Barglow, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Quail Avenue, Berkeley, CA 94708 Phone: 510-540-8156 Fax: 510-295-2744 | |
John George Rosenberg, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2417 Carleton St, Berkeley, CA 94704 Phone: 510-984-7811 | |
Dr. Anthony Adrian Rienzi, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2001 Dwight Way, Suite 4190, Berkeley, CA 94704 Phone: 510-204-4635 Fax: 510-204-3060 | |
Dr. Leslie Aaron Tsang, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 900 Colusa Ave Ste 205a, Berkeley, CA 94707 Phone: 415-706-4509 Fax: 510-295-2567 | |
Dr. Daiana J Harper, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2001 Dwight Way, Suite 4190, Berkeley, CA 94704 Phone: 510-204-4635 |